Dr Jeremy Wilkinson, Microbial Genomics Lead, PacBio, explores how genomics are enabling higher-resolution microbiome profiling and highlights four therapeutic areas where this new layer of genomic precision is beginning to shape drug discovery and development.  Over the past decade, the gut microbiome has gone from a scientific curiosity to a central theme in many life […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!